A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions

NCT03843541 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

333

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Tract Diseases
Abnormal Mucus Secretions

Interventions

DRUG: N-acetylcysteine (NAC) 600 mg
DRUG: Ambroxol hydrochloride 30 mg
OTHER: placebo

Sponsor

Zambon SpA